Medicare Enrolled
Dr. Ibrahim Almeky, MD
Hospitalist Physician · Kingston, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Almeky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almeky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Almeky
Dr. Ibrahim Almeky is a hospitalist physician in Kingston, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Almeky performed 5,829 Medicare services across 2,142 unique beneficiaries.
Between the years covered by Open Payments, Dr. Almeky received a total of $3,503 from 35 pharmaceutical and/or device companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Almeky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in PA
$3,503 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,829
Medicare services
Top 1% in PA for hospitalist physician
2,142
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~307 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
1,598 | $79 | $149 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
923 | $55 | $90 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
772 | $91 | $130 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
485 | $30 | $52 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
296 | $58 | $175 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
215 | $138 | $199 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
181 | $61 | $90 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
159 | $84 | $200 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
158 | $60 | $120 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
96 | $41 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
91 | $72 | $220 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
89 | $88 | $180 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
83 | $131 | $225 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
79 | $54 | $125 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
76 | $58 | $200 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
69 | $102 | $195 |
| Home visit, established patient, straightforward decision making A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service. |
68 | $32 | $85 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
55 | $36 | $125 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
53 | $37 | $140 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
48 | $22 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
47 | $29 | $30 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
42 | $90 | $229 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $30 | $110 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
27 | $39 | $75 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
22 | $60 | $150 |
| COVID-19 vaccine (Moderna bivalent) An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose. |
17 | $143 | $250 |
| SARS-CoV-2 vaccine, 30 mcg/0.3 mL Administration of the SARS-CoV-2 (COVID-19) vaccine containing 30 micrograms of antigen in a 0.3 milliliter dose. |
16 | $39 | $75 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
14 | $14 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $96 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,503
Total received (2018-2024)
Avg $500/year across 7 years
Top 4% in PA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
199
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,475 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$632
2023
$424
2022
$363
2021
$371
2020
$576
2019
$420
2018
$716
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$190
AstraZeneca Pharmaceuticals LP
$140
Indivior Inc.
$95
GlaxoSmithKline, LLC.
$56
Novartis Pharmaceuticals Corporation
$30
Teva Pharmaceuticals USA, Inc.
$28
AIMMUNE THERAPEUTICS, INC.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
PFIZER INC.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Amgen Inc.
$17
Top 3 companies account for 67.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$635
AstraZeneca Pharmaceuticals LP
$445
GlaxoSmithKline, LLC.
$278
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$238
PFIZER INC.
$232
BioFire Diagnostics, LLC
$172
Janssen Pharmaceuticals, Inc
$170
Novartis Pharmaceuticals Corporation
$164
Lilly USA, LLC
$158
Astellas Pharma US Inc
$110
Indivior Inc.
$95
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Daiichi Sankyo Inc.
$84
Sunovion Pharmaceuticals Inc.
$73
Smith & Nephew, Inc.
$64
UCB, Inc.
$63
Avanir Pharmaceuticals, Inc.
$42
Xeris Pharmaceuticals, Inc.
$42
Amgen Inc.
$34
Bayer HealthCare Pharmaceuticals Inc.
$34
Allergan, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$28
Abbott Laboratories
$23
LINUS HEALTH, INC.
$21
AIMMUNE THERAPEUTICS, INC.
$20
AbbVie Inc.
$19
OptiNose US, Inc.
$19
ABBVIE INC.
$18
Nabriva Therapeutics, plc
$18
Shield Therapeutics Inc
$16
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$15
Genentech USA, Inc.
$15
Kyowa Kirin, Inc.
$14
Sanofi Pasteur Inc.
$14
Alkermes, Inc.
$12
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · APTIOM · Austedo XR · BEVESPI AEROSPHERE · BEXSERO · BYDUREON · BioFire FilmArray · CHANTIX · CORE COGNITIVE EVALUATION · DALVANCE · EMGALITY · ENTRESTO · FARXIGA · GVOKE PFS · HUMALOG · INJECTAFER · INVOKANA · Infinity DBS Pulse Generators · JARDIANCE · Kerendia · LOKELMA · LONHALA MAGNAIR · LifeVest · MOUNJARO · MYRBETRIQ · NUEDEXTA · Nayzilam · Nourianz · Otezla · Ozempic · PENTACEL · PREVNAR 13 · PREVNAR 20 · QULIPTA · RYBELSUS · Rybelsus · SPIRIVA RESPIMAT · SUBLOCADE · SYMBICORT · Santyl · Saxenda · Sivextro · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Utibron · VIVITROL · VRAYLAR · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · Xhance · Xofluza · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for hospitalist physician in PA.
Geographic Context
Hospitalist physicians within 10 mi
29
Per 100K population
8.9
County median income
$62,321
Nearest hospital
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
12.5 mi
12.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Almeky is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 4% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Almeky experienced with nursing facility visit, moderate complexity?
Based on Medicare claims data, Dr. Almeky performed 1,598 nursing facility visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Almeky receive payments from pharmaceutical companies?
Yes. Dr. Almeky received a total of $3,503 from 35 companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almeky's costs compare to other hospitalist physicians in Kingston?
Dr. Almeky's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almeky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in Kingston
Browse hospitalist physicians in Kingston ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in PA
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in PA
Which PA hospitalist physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology